Brief: Onxeo S.A. says combination of AsiDNA and PARP inhibitors demonstrates synergistic effect
07/09/2016 17:03
Sept 7 (Reuters) - Onxeo S.A.:
* Onxeo S.A.: combination of AsiDNA and PARP inhibitors
demonstrates synergistic effect, bypasses genetic restriction
Source text for Eikon: ID:nBw13rZzva
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln